Pharma Tech Holdings SA Obtains a Capital Commitment Agreement of CHF 30 million from Global Investor LDA Capital

LUGANO, Switzerland–(BUSINESS THREAD)–Pharma Tech Holding SA (“PTH”) today announced that it has secured an investment of CHF 30 million to support its portfolio investments from LDA Capital Ltd, a global investment group with experience in transactions cross-border, such as agriculture, Agri-tech, and CBD industries.

Founded in 2019, PTH is a Swiss-based holding company that invests in innovative companies with high technological value and scalability potential, primarily in Switzerland and Europe, with a focus on health technology, agritech and functional foods

This investment will enable PTH to primarily invest in and support its portfolio company Blue Sky Swisse SA (“BSS”), a JV between PTH and the listed company IGEA PHARMA NV (“Igea”), IGPH – ISIN NL0012768675. BSS focuses on the extraction of natural active principles from plant matrices, plant waste and renewable sources to offer B2B products in the form of CBD oil, terpenes and waxes. The factory located in Biasca, will be built using the latest supercritical CO2 extraction technology and will be energetically self-sufficient through the use of photovoltaic solar panels and district heating. BSS will grant the highest quality of CBD also thanks to a patented extraction process, starting from the cultivation carried out under strict control and culminating in the immediate freezing of the flowers after the harvest, with the aim of also selling formulations “all the natural” to increase bioavailability thus. enhancing the possible applications. Last but not least, BSS will invest in the chain of agricultural raw materials and create an aeroponic greenhouse in Ticino, to offer a high quality GMP pharmaceutical CBD oil.

LDA Capital agreed to commit an amount of up to CHF 30 million (the “Capital Commitment”) in cash over a maximum period of three years. This Capital Commitment will be released based on PTH’s provisions, which PTH has the right to exercise at its discretion.

“We are delighted with this partnership and very pleased that LDA Capital recognizes the value of PTH and its portfolio company, with the aim of creating one of the most innovative hubs for health, agriculture and food technology functional,” he said. Sabina Del Nigro, CEO of PTH.

About Pharma Tech Holding: Pharma Tech Holding SA (PTH) is a holding company based in Lugano, Switzerland that invests in innovative companies with high technological value and potential for scalability, mainly in Switzerland and Europe, with a focus on technology of health, Agrotechnological and functional food.

About LDA Capital: LDA Capital is a global alternative investment group with expertise in cross-border transactions worldwide. Our team has dedicated their careers to international and cross-border opportunities having collectively executed more than 250 transactions in both the public and private middle market in 43 countries with aggregate transaction values ​​in excess of US$11 billion. For more information, visit: www.ldacap.com; For inquiries please email: info@ldacap.com.

Source link

You May Also Like

About the Author: SteveSossin

Welcome! I keep up on all the latest cbd and thc news!